期刊文献+

基因芯片检测HBV DNA及YMDD变异的临床意义

下载PDF
导出
出处 《中西医结合肝病杂志》 CAS 2006年第3期169-170,共2页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
  • 相关文献

参考文献4

二级参考文献6

  • 1[1]Fattovich G,Brollo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis type B. Gut, 1991 ;32(3) :294~298
  • 2[2]Chang CN,Skalski V,Zhou JH et al. Biochemical pharmacology of( + ) and ( - )-2' ,3'-dideoxy-3'-thiacytidine as anti-hepatitis B virusangets. J Biol Chem, 1992;267(31) :22414~22420
  • 3[3]Coates JAV, Cammack N, Jenkinson HJ et al. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit humanimmunodeficiency virus replication in vitro. Antimicrob AgentsChemother, 1992; 36 ( 1 ): 202~205
  • 4[4]Honkoop P, De-Man RA, Zondervan PE et al. Histological improvement in patients with chronic hepatitis B virus infection treatedwith lamivudine. Liver, 1997;17(2): 103~106
  • 5[5]Bartholomew MM,Jansen RW, Jeffers LJ et al. Hepatitis B virusresistance to lamivudine given for recurrent infection after orthotopicliver transplantation. Lancet, 1997;349(9044) :20~22
  • 6Yuen MF, Sablon E, Hui CK,et al. Factors associated with he-patitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology, 2001, 34:785-791.

共引文献14014

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部